Rights and permissions
About this article
Cite this article
UFH best bet for preventing postop VTE in ovarian cancer?. Pharmacoecon. Outcomes News 634, 7 (2011). https://doi.org/10.2165/00151234-201106340-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106340-00020